Related Experiment Video
Updated: May 3, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-A Hybrid Effectiveness-Implementation Pilot
Hanne Birke1, Sidsel Maria Jørgensen1, Laura Victoria Jedig Lech2
1Center for Clinical Research and Prevention (HB, SMJ, MLS), Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Objectives:
The aim of DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE) was to evaluate a multifaceted intervention to reduce antipsychotic use among nursing home residents with dementia without medication shifts (increase in the use of other psychotropic medications) or worsening Behavioral and Psychological Symptoms of Dementia (BPSD).
Methods:
From June 2022 to January 2024, a type 2 hybrid effectiveness-implementation pilot study was conducted across six Danish nursing homes. The intervention included education for general practitioners and healthcare professionals, medication reviews, and individualized care plans for 40 residents with dementia using antipsychotic medications. The data collection focused on implementation, antipsychotic use, psychotropic medication use, and BPSD. Implementation was assessed through fidelity analysis and surveys assessing providers' perceptions of the models' acceptability, appropriateness, feasibility, and healthcare providers' self-reported knowledge and competence. Changes in antipsychotic use, medication shifts, and BPSD scores measured effectiveness.
Results:
Fidelity was generally high, but participation in education was low. About half of the respondents considered the model appropriate and feasible. The intervention led to a significant reduction in antipsychotic use among the 40 included residents, with a decrease of 97.6 mg in olanzapine equivalents corresponding to a daily mean use of 5.9 mg olanzapine equivalents at baseline to a daily mean use of 4.8 mg, at study end (averaged reduction of 1.1 mg/day). In total, 36% of the residents achieved ≥50% reductions, and without an increase in the use of other psychotropic drugs or worsening of BPSD.
Conclusions:
DECADE reduced antipsychotic use without worsening BPSD, highlighting its potential for broader applications. Multidisciplinary collaboration and ongoing education regarding antipsychotic use in dementia care are essential.
More Related Videos
10:29A Complex Diving-For-Food Task to Investigate Social Organization and Interactions in Rats
Published on: May 8, 2021
06:15Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
Published on: January 9, 2026
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
Alzheimer's Disease: Treatment
Drug Therapy
Antianxiety Medications